+ Follow SKIN AND SURGERY SPECIALISTS Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 133766
[Title] => Hope for hair loss sufferers
[Summary] => Male pattern hair loss (MPHL), or androgenetic alopecia, is a perennial cause of concern and frustration for a large segment of the male population. It has been estimated that nearly fifty percent of all men will experience hair loss during their lifetime.
But there is hope, as advances in the science of hair loss have spurred the development of a class of drugs that targets an enzyme that plays a major role in the baldness process.
[DatePublished] => 2001-09-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1375589
[AuthorName] => Jay P. Nuñez, MD
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
SKIN AND SURGERY SPECIALISTS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 133766
[Title] => Hope for hair loss sufferers
[Summary] => Male pattern hair loss (MPHL), or androgenetic alopecia, is a perennial cause of concern and frustration for a large segment of the male population. It has been estimated that nearly fifty percent of all men will experience hair loss during their lifetime.
But there is hope, as advances in the science of hair loss have spurred the development of a class of drugs that targets an enzyme that plays a major role in the baldness process.
[DatePublished] => 2001-09-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1375589
[AuthorName] => Jay P. Nuñez, MD
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest